Total Payments
$2,112
2024 Payments
$686.47
Companies
18
Transactions
91
Medicare Patients
1,103
Medicare Billing
$129,971
Payment Breakdown by Category
Food & Beverage$2,032 (96.2%)
Education$79.99 (3.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,032 | 90 | 96.2% |
| Education | $79.99 | 1 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $421.87 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $338.05 | 17 | $0 (2024) |
| Gilead Sciences, Inc. | $317.90 | 11 | $0 (2024) |
| Astellas Pharma US Inc | $187.21 | 5 | $0 (2024) |
| Shionogi Inc | $163.92 | 8 | $0 (2023) |
| La Jolla Pharmaceutical Company | $116.33 | 4 | $0 (2024) |
| Theratechnologies Inc. | $113.95 | 5 | $0 (2024) |
| ABBVIE INC. | $100.26 | 5 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $69.06 | 3 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $57.55 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $686.47 | 25 | Gilead Sciences, Inc. ($171.14) |
| 2023 | $819.35 | 35 | ViiV Healthcare Company ($226.43) |
| 2022 | $541.66 | 26 | ViiV Healthcare Company ($129.41) |
| 2021 | $64.84 | 5 | Gilead Sciences, Inc. ($39.09) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: HIV | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/18/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: HIV | ||||||
| 09/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.42 | General |
| 09/12/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $133.88 | General |
| Category: HCV | ||||||
| 08/21/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Infectious Diseases | ||||||
| 08/20/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.84 | General |
| 08/01/2024 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 07/25/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug), ZINPLAVA, RECARBRIO | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/23/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/26/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: HIV | ||||||
| 06/18/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/19/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Respiratory | ||||||
| 03/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2024 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Food and Beverage | In-kind items and services | $36.75 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/15/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/12/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: HIV | ||||||
| 02/27/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: Infectious Diseases | ||||||
| 02/22/2024 | Hologic Sales and Service, LLC | APTIMA (Device), THINPREP 2000 PROCESSOR | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: Diagnostics | ||||||
| 02/15/2024 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $39.73 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 02/13/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/26/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: HIV | ||||||
| 01/22/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 234 | 883 | $149,967 | $30,239 |
| 2022 | 6 | 257 | 729 | $142,804 | $30,834 |
| 2021 | 3 | 241 | 807 | $115,990 | $27,675 |
| 2020 | 6 | 371 | 874 | $110,485 | $41,223 |
Total Patients
1,103
Total Services
3,293
Medicare Billing
$129,971
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 96 | 730 | $95,630 | $18,928 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 64 | $24,960 | $5,187 | 20.8% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 43 | 44 | $11,792 | $2,369 | 20.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $10,647 | $2,270 | 21.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $6,743 | $1,376 | 20.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 13 | 13 | $195.00 | $109.20 | 56.0% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 82 | 526 | $68,906 | $15,157 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 82 | 107 | $41,730 | $8,685 | 20.8% |
| 99304 | Initial nursing facility visit per day, typically 25 minutes | Facility | 2022 | 44 | 46 | $12,328 | $2,677 | 21.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $11,661 | $2,443 | 20.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 13 | $7,969 | $1,831 | 23.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 14 | $210.00 | $41.31 | 19.7% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 130 | 686 | $81,773 | $19,521 | 23.9% |
| 99304 | Initial nursing facility visit, typically 25 minutes per day | Facility | 2021 | 71 | 72 | $17,902 | $4,223 | 23.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 49 | $16,315 | $3,931 | 24.1% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2020 | 92 | 529 | $44,965 | $16,115 | 35.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 145 | 208 | $36,400 | $14,020 | 38.5% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 33 | 33 | $11,550 | $4,038 | 35.0% |
| 99304 | Initial nursing facility visit, typically 25 minutes per day | Facility | 2020 | 60 | 62 | $10,850 | $3,906 | 36.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 29 | 29 | $6,525 | $3,106 | 47.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 12 | 13 | $195.00 | $38.76 | 19.9% |
About Mark Nuguid, APRN
Mark Nuguid, APRN is a Registered Nurse healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2017. The National Provider Identifier (NPI) number assigned to this provider is 1447785290.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mark Nuguid, APRN has received a total of $2,112 in payments from pharmaceutical and medical device companies, with $686.47 received in 2024. These payments were reported across 91 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,032).
As a Medicare-enrolled provider, Nuguid has provided services to 1,103 Medicare beneficiaries, totaling 3,293 services with total Medicare billing of $129,971. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Tampa, FL
- Active Since 04/28/2017
- Last Updated 06/18/2024
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1447785290
Products in Payments
- DOVATO (Drug) $328.20
- PIFELTRO (Drug) $197.57
- Fetroja (Drug) $163.92
- Epclusa (Drug) $133.88
- EGRIFTA (Drug) $113.95
- Cresemba (Drug) $107.22
- DIFICID (Drug) $90.00
- XERAVA (Drug) $79.58
- RUKOBIA (Drug) $73.41
- LIVTENCITY (Drug) $69.06
- Arikayce (Drug) $53.63
- AVYCAZ (Drug) $43.73
- DALVANCE (Drug) $39.29
- NUZYRA (Drug) $37.70
- XACDURO (Drug) $36.75
- VIBATIV (Drug) $32.59
- ZERBAXA (Drug) $27.74
- REBYOTA (Biological) $25.82
- APTIMA (Device) $25.24
- PREVYMIS (Drug) $22.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Tampa
Rebekah Rharad, Aprn, Rn, APRN, RN
Registered Nurse — Payments: $28,349
Registered Nurse $28,349
Mrs. Casey Viera, Arnp, ARNP
Registered Nurse — Payments: $15,317
Registered Nurse $15,317
Ms. Suecarla Adams, Aprn, APRN
Registered Nurse — Payments: $6,688
Registered Nurse $6,688
Yessenia Marmol, Aprn, APRN
Registered Nurse — Payments: $1,971
Registered Nurse $1,971
Miss. Maria Estrada, Arnp, ARNP
Registered Nurse — Payments: $1,291
Registered Nurse $1,291
Yaime Alayo Linton
Registered Nurse — Payments: $1,243
Registered Nurse $1,243